AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 284: R481-R485, 2003. First published November 21, 2002; doi:10.1152/ajpregu.00078.2002
0363-6119/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/2/R481    most recent
00078.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howlett, R. A.
Right arrow Articles by Hogan, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howlett, R. A.
Right arrow Articles by Hogan, M. C.
Vol. 284, Issue 2, R481-R485, February 2003

Dichloroacetate accelerates the fall in intracellular PO2 at onset of contractions in Xenopus single muscle fibers

Richard A. Howlett and Michael C. Hogan

Department of Medicine, University of California, San Diego, La Jolla, California 92093-0623


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study investigated the relationship between intracellular PO2 (PIO2) and dichloroacetate (DCA) administration following a significant step-change increase in oxidative metabolism in intact isolated Xenopus single muscle fibers. Single fibers (n = 22) were dissected from the lumbrical muscle, injected with the oxygen-sensitive compound palladium-meso-tetra (4-carboxyphenyl) porphine, and randomly assigned to one of two treatment groups. One group (DCA; n = 12) was incubated for 30 min with 1.2 mM DCA, whereas the second group [control (Con); n = 10] was incubated for 30 min in Ringer solution only. After incubation, fibers were electrically stimulated to elicit tetanic contractions (0.5 Hz) for 2 min during which PIO2 was monitored. PIO2 before contractions began was 32.0 ± 1.8 and 29.0 ± 1.8 Torr for DCA and Con, respectively, and fell to 6.0 ± 1.3 and 8.8 ± 2.4 Torr (no significant difference), respectively, after steady state was reached. The kinetics of the fall, determined by both the time delay (from the start of contractions to the initial decrease in PIO2) and the tau (63% of the change to a steady state in PIO2), were calculated. In DCA cells, the tau was significantly (P < 0.05) faster than Con (22.1 ± 3.6 vs. 39.7 ± 5.8 s). In contrast, the time delay was not significantly (P > 0.45) different between the two groups (11.4 ± 1.7 vs. 12.6 ± 2.3 s, respectively). The amount of fatigue, reflected by a decrease in force production from initial, was not significantly different between groups. These data suggest that by stimulating pyruvate dehydrogenase with DCA in isolated single skeletal muscle cells, the faster fall in PIO2 is indicative of oxidative metabolism being more rapidly activated. This is the first evidence that oxygen uptake at the onset of contractions may be altered by DCA during moderate- to high-intensity contractile activity.

oxygen kinetics; oxidative metabolism; pyruvate dehydrogenase; metabolic inertia; fatigue


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

THE MECHANISMS that regulate the onset kinetics of oxidative metabolism at the start of exercise have been well studied in recent years. Much of the research into these mechanisms has focused on whether the rate of oxidative phosphorylation is controlled by so-called exogenous factors, such as blood flow and/or oxygen delivery (26), or by intrinsic factors, such as cellular regulators or metabolic activation (30).

Several studies demonstrated previously that the administration of dichloroacetate (DCA) under a variety of conditions results in a decreased reliance on nonoxidative ATP production at the onset of exercise, as reflected in a decrease in both the accumulation of muscle lactate and the decline in muscle phosphocreatine (PCr) content, whether in exercising humans (13, 24) or in contracting dog muscle (25). As DCA is a stimulator of the pyruvate dehydrogenase (PDH) complex (29), it has been suggested that an activation of PDH by DCA allows for greater flux of carbohydrate-derived carbon into the TCA cycle, allowing for greater oxygen utilization at the onset of exercise. However, this rise in oxidative metabolism, while remaining the most likely explanation for the decrease in nonoxidative ATP production, has yet to be directly shown experimentally. To date, few studies have attempted to measure VO2 on-kinetics with DCA in working skeletal muscle at the onset of contractions, and these have found no difference in the rate of increase in VO2 in either humans or isolated dog muscle (1, 9). However, changes in O2 uptake kinetics may be difficult to measure across contracting human or canine skeletal muscle, and the work intensity employed may be an important factor in whether PDH activation influences onset kinetics.

Recently, our lab published several papers on the relationship between intracellular PO2 (PIO2) and muscle contraction in intact Xenopus single skeletal muscle fibers using a porphyrin phosphorescent probe for the measurement of PIO2. Initial experiments showed that PIO2 fell at the onset of contractions and recovered when contractions ended (11). This fall was subsequently shown to 1) occur with a rate constant similar to whole body or isolated muscle VO2 (12), 2) be more rapid on subsequent bouts following a "priming" contractile period (12), and 3) to have a magnitude linearly related to stimulation frequency and thus energy demand (15). The results of these previous studies suggest that our method of measuring PIO2 is extremely useful for investigating cellular oxidative metabolism in a skeletal muscle model in which external factors can be tightly controlled.

The purpose of the present study was to quantify the changes in PIO2 at the onset of moderate-intensity contractile activity with DCA administration. By using isolated intact single skeletal muscle fibers, this investigation avoids many confounding factors that make whole muscle studies difficult to interpret. Because DCA has been suggested to affect oxidative metabolism during muscle contractions, our hypothesis was that PIO2 would fall more rapidly in DCA-treated cells than control (Con) cells, likely reflecting a faster increase in VO2 at the onset of exercise.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animal care. All procedures were approved by the University of California San Diego animal care and use committee and conform to National Institutes of Health guidelines. Female adult Xenopus laevis were doubly pithed and decapitated and the lumbrical muscles (II-IV) were dissected free from the hindfeet.

Measurement systems. All dissections and experiments were conducted at 20°C. Single living muscle fibers (n = 22) were microdissected from the lumbrical muscle strips with tendons intact in a chamber filled with Ringer solution (112 mM NaCl, 1.87 mM KCl, 0.82 mM CaCl2, 2.38 mM NaHCO3, 0.07 mM NaH2PO4, 0.1 mM EGTA; pH 7.0). A mix of muscle fiber types was used and these single fibers average ~60-100 µg wet wt. Intact cells were microinjected with a solution of 0.5 mM palladium-meso-tetra(4-carboxyphenyl)porphine bound to bovine serum albumin (containing 10 mM fura-2 for visual monitoring) by micropipette pressure injection (World Precision Instruments PV830 pneumatic picopump, Sarasota, FL). Experiments are only performed on fibers with visually intact plasma membranes that exhibit normal contractile properties and that do not display any difficulties in propagating action potentials in response to electrical stimulation.

Phosphorescence signals were recorded using a Nikon 40× Fluor objective (0.70 numerical aperture) used dry. The phosphorescence quenching of the Pd-porphyrin oxygen probe within each cell was measured through a system consisting of a flash lamp (Oxygen Enterprises, Philadelphia, PA), a 425-nm band pass excitation filter, a 630-nm cut-on emission filter, and a photomultiplier tube for collection of the phosphorescence signal. To calculate phosphorescence lifetimes from the intracellular O2 probe, the phosphorescent decay curves from a series of 10 flashes (15 Hz) were averaged and a monoexponential function was fit to the subsequent best-fit decay curve (analysis software from Medical Systems, Greenvale, NY). Phosphorescent decay curves were recorded every 4 s from each cell throughout the experimental period. Previously determined values for the measured phosphorescence lifetime decay in a zero oxygen environment and the phosphorescence quenching constant for the intracellular oxygen probe were used to calculate PIO2 (11). As the oxygen tension decreases in the environment around the porphyrin compound, the phosphorescence lifetime (after a single flash of light) lengthens in a systematic manner (28). This technique has been previously validated for the measurement of PIO2 within single skeletal muscle cells injected with the porphyrin compound (11). In that investigation, cellular respiration was abolished with inhibitors, allowing the PIO2 to equilibrate with the extracellular PO2. With the use of solutions with known standard PO2, the response of the porphyrin was then calibrated.

Experimental protocol. Platinum clips were attached to the tendons of the cells and they were mounted in a chamber filled with Ringer solution. One end of the fiber was fixed and the other free end was attached to an adjustable force transducer (Aurora Scientific, model 400A, Aurora, Ontario), allowing the muscle to be set at a length (Lo) that produced maximal tetanic force (Po). The analog signal from the force transducer was sampled at 200 Hz and converted to a digital signal via an MP100WSW A-D converter and analyzed with AcqKnowledgeIII 3.2.6 analysis software (Biopac Systems, Santa Barbara, CA). Fatigue was standardized by comparing force at the end of the stimulation protocol to the maximal tetanic force (P/Po).

Before stimulation, fibers were incubated in standard Ringer solution (plus 4 mM glucose) with 1.2 mM DCA (n = 12) or without (Con; n = 10) for 30 min. The concentration of DCA for the present study was chosen to be close to the effective concentration resulting from the 100-mg/kg dose used in previous investigations using humans (13, 14) in which PDH activation was shown to be among the highest ever reported. At the start of the stimulation, the chamber was perfused with Ringer equilibrated with a gas mixture to produce a PO2 of ~30 Torr. As the normal in vivo PO2 value surrounding Xenopus skeletal muscle is not known, this PO2 value represents an approximate published mean capillary PO2 value for mammalian tissue (19, 20). Constant perfusion was maintained throughout the protocol to maintain the experimental PO2 and to reduce the possible occurrence of unstirred layers surrounding the cell.

Tetanic contractions were elicited using direct (8-10 V) stimulation of the muscle (Grass model S48, Warwick, RI). Stimulation consisted of 200-ms trains of 70-Hz impulses of 1-ms duration. After a resting 20-s initial recording period, fibers were stimulated for 2 min at 0.5 Hz.

Calculations. Data were examined blind to the treatment. All data were plotted for kinetic fitting of the fall in PIO2 using Kaleidagraph data analysis software (Synergy Software, Reading, PA). A monoexponential curve fit model incorporating a time delay was used. It is represented as
P<SC>o</SC><SUB>2</SUB>(<IT>t</IT>) = P<SC>o</SC><SUB>2</SUB>(b) − A × [1 − <IT>e</IT><SUP>−(<IT>t</IT> − TD)/&tgr;</SUP>]
where t is time after contractions begin, b is baseline or starting PO2, A is the amplitude of the fall to steady-state PIO2, TD is the time delay, and tau  is the time constant.

Statistics. All values are presented as means ± SE. To test for significance, a Student's t-test for independent samples for each variable was performed between the two groups. The level of significance was set at P < 0.05 throughout.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

PO2 kinetic analysis. Figure 1 shows representative data from a single DCA and a single Con fiber showing the method of curve fit. Plotted data were fit with a single time delay and a monoexponential fall in PIO2. The model parameters for each fiber are shown on Fig. 1.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Individual data for representative Control (Con; top dashed line) and dichloroacetate (DCA; bottom solid line) fibers. The superimposed solid lines show the curve fit for the respective cells. The model parameters from the fitted data are listed on the figure. The arrow shows the onset of contractions. b, Baseline or starting PO2; A, amplitude of the fall to steady-state intracellular PO2 (PIO2); TD, time delay; and tau , time constant.

Intracellular PO2. Figure 2 is a plot of the fall in PIO2 during the measurement period for both Con and DCA groups. The mean data for all cells in both conditions are shown. The more rapid fall in PIO2 is clearly evident in the DCA group. Resting PIO2 (32.0 ± 1.8 vs. 29.0 ± 1.8 Torr; DCA vs. Con) and steady-state PIO2 (6.0 ± 1.3 and 8.8 ± 2.4 Torr; DCA vs. Con) values were not significantly different between groups.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Relationship between intracellular PO2 and time during the entire stimulation period for Con () and DCA (open circle ) groups. The plot is raw mean data for all cells (error bars omitted for clarity). Note the more rapid fall in PO2 in the DCA group. The arrow represents the start of tetanic contractions.

Time delay. The time between the onset of electrically stimulated contractions and the first fall in PIO2 is the time delay. The lack of significant difference in time delay between groups is seen in Table 1.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Kinetic parameters for the fall in intracellular PO2 and the amount of relative fatigue during the experimental stimulation protocol for Con and DCA cells

Tau. The time constant (tau) represents the time to reach 63% of the difference between the higher resting PIO2 and the low steady-state PIO2. Table 1 demonstrates how the time constant for the fall in PIO2 is significantly faster for DCA cells than for Con.

Force. The relative amount of fatigue in both experimental conditions, expressed as the force developed at the end of stimulation compared with initial force production, is shown in Table 1. There was no significant difference in the amount of fatigue produced by 2 min of stimulation between the Con and DCA groups.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The results of this study demonstrated that administration of DCA to intact single skeletal muscle cells before the onset of contractions resulted in a significantly faster fall in intracellular PO2 from resting levels during the contractile period. This is the first evidence that skeletal muscle oxidative metabolism may be altered by DCA during contractions. Although VO2 was not measured directly in the present study, due to the relationship between VO2 and PO2
<A><AC>V</AC><AC>˙</AC></A><SC>o</SC><SUB>2</SUB> = D<SC>o</SC><SUB>2</SUB> (extracellular P<SC>o</SC><SUB>2</SUB> − intracellular P<SC>o</SC><SUB>2</SUB>)
(where DO2 is the coefficient of diffusion) it is expected that VO2 will rise with any decrease in measured PIO2 as the other parameters should remain constant. Previous studies demonstrated that intense electrical stimulation will elicit a large increase in VO2 in these cells within 1-2 min (3, 27) and that increased stimulation frequency will elicit greater falls in PIO2 and thus increased VO2 (15).

In previous studies using DCA administration, the changes in oxidative metabolism have been inferred from a decrease in nonoxidative ATP production in working muscle. These changes include decreased PCr utilization and decreased muscle lactate production (13, 23). Very few studies to date, however, have attempted to directly measure VO2 kinetics with DCA, and these have demonstrated that faster VO2 kinetics do not appear to occur with the administration of DCA whether in animal (9) or human models (1). The reason(s) for the discrepancy between the present result showing significant changes in the fall in PIO2 and the failure thus far to show VO2 changes with DCA could be several. First, it is possible that the differences in oxidative metabolism between treatments are not large enough to be easily measured in whole muscle preparations (human or animal). Due to the efficiency of oxidative metabolism, the relatively large decrease in nonoxidative ATP production is counterbalanced by very little oxygen utilization. It may be very difficult to measure such small differences in VO2 caused by DCA administration using pulmonary or arteriovenous (Fick) measurement of VO2 without repeated measurements during the crucial period at the onset of exercise. Second, speeding of oxygen uptake kinetics by various interventions is often, but not always, seen only when work rate is high (i.e., above lactate threshold). In contracting dog muscle, when blood flow was kept very high before the onset of contractions, VO2 kinetics were not significantly accelerated at submaximal work rates (7) but were at VO2 max (10). This has also been shown in humans when priming exercise is done (5, 18). In those human studies, differences in VO2 kinetics (primarily via a reduction in VO2 slow component) were present in a second bout of exercise only when the work rate was above ventilatory threshold. Conversely, DCA administration has been shown to be ineffective when exercise is done at higher workloads, such as 110% of VO2 max (1) or during very intense (>250% VO2 max) isokinetic cycling (14). Therefore, it appears that the range of intensity is crucial for demonstrating large changes in VO2 kinetics in any model. In the present study, an isometric contraction frequency was chosen that has previously been shown to both cause a rapid and large decrease in PIO2 (15) and also be sustainable for several minutes (12). Although it is difficult to precisely quantify the relative intensity of this contraction regime, the rate of fatigue suggests that it is moderate to heavy domain but likely below that which would elicit VO2 max, even though this would of course vary somewhat by fiber type. Finally, it is possible that the effect(s) of DCA are simply easier to measure in a single cell model where issues of blood flow, fiber recruitment, muscle/blood/expired gas sampling, and/or drug delivery are negligible.

The present study sheds some light on the current controversy regarding the control of oxidative metabolism (6, 16). Much has been written in the past years about whether the rate at which oxidative phosphorylation activation is controlled by either extrinsic factors (i.e., blood flow and/or oxygen delivery) or intrinsic factors (i.e., activation of key enzymes or "metabolic inertia") (6, 7, 27). However, the exact contribution of intrinsic and extrinsic factors in vivo can be difficult to assess and is influenced by the experimental conditions. The isolated single fiber model used for the present study is optimal for studying this question as extrinsic factors can be tightly controlled. Unlike in perfused skeletal muscle, where blood flow distribution may be problematic (6), there is no heterogeneity of blood flow or oxygen delivery as the single cell is completely perfused. The present data suggest that even when extrinsic factors are kept optimal, there is still a delay in the onset of oxidative metabolism, confirming the previous work done in single fibers (12). Furthermore, our results suggest that the rate of activation of oxidative metabolism can be increased by affecting one of the key enzymes in the pathways, PDH. Metabolic inertia has been shown previously in studies of isolated dog muscle when blood flow is enhanced at the onset of contractions (8) or when offloading of oxygen is increased (10). In both of those studies, greater delivery of oxygen did not change VO2 kinetics, suggesting an inherent lag in oxygen utilization distal to oxygen delivery. Likewise, it was demonstrated that microvascular PO2 does not fall immediately with exercise, demonstrating that systemic oxygen delivery is not limiting to oxidative metabolism at the onset of contractions (2). They further suggest that the delay in VO2 onset in that model is therefore due to metabolic inertia since O2 delivery is sufficient. A recent study by Kindig et al. (17) used the nitric oxide (NO) synthase blocker NG-nitro-L-arginine methyl ester (L-NAME) during exercise in horses and demonstrated an acceleration in VO2 kinetics. These authors believe that this is due to relieving a direct inhibition of oxidative phosphorylation by NO and not due to differences in blood flow. Because there is evidence that NO may not play a large role in regulating exercise blood flow in humans (22), it is hard to say if blood flow in the L-NAME condition was depressed due to blocking the normal vasodilatory effects of NO (21), but it would certainly not be expected to be any greater than without L-NAME. Because the model used in the present study has no intact circulation, our results cannot address whether blood flow does play a role in affecting VO2 kinetics or not. However, it does agree with previous studies that cellular mechanisms do play a role in determining oxygen uptake kinetics.

One interesting result from the present study is that the acceleration in intracellular PO2 reduction due to DCA occurs primarily due to a decreased time constant (tau) and not due to a decreased time delay. This is in contrast to a previous study using this model to look at repetitive contractile periods (12). In that study, the overall VO2 kinetic response was faster following a prior warm-up series of contractions due mainly to a relatively large (80%) decrease in the time delay before activation. One possible explanation for these results is the loci of metabolic activation in the different protocols. In the present (DCA) study, PDH is presumably the only activated regulatory enzyme, whereas in the previous study, downstream regulatory points such as other dehydrogenases, TCA cycle flux, or cytochromes may be affected by prior exercise. Why the additional regulatory points would affect primarily the time delay is not presently known. It is clear that PDH activation itself is very important in reducing nonoxidative ATP production at the onset of contractions as demonstrated by several DCA studies. This is in contrast to increasing only PDH product (i.e., acetyl-CoA and acetylcarnitine) alone, which has no effect on PCr or lactate at the onset of exercise (4).

In summary, the present study demonstrates in single skeletal muscle fibers that DCA administration will accelerate the fall in intracellular PO2 at the onset of exercise. This suggests that PDH activation is a major regulator for oxidative phosphorylation in these single amphibian fibers. In addition, the results support several other studies that show that metabolic inertia certainly does play a role in VO2 onset kinetics in these cells.


    ACKNOWLEDGEMENTS

This study was supported by National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR-40155. R. Howlett was a National Sciences and Engineering Research Council Canada postdoctoral fellow.


    FOOTNOTES

Address for reprint requests and other correspondence: R. A. Howlett, Dept. of Medicine 0623A, Univ. of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0623 (E-mail: rhowlett{at}ucsd.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

First published November 21, 2002;10.1152/ajpregu.00078.2002

Received 7 February 2002; accepted in final form 13 November 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Bangsbo, J, Gibala MJ, Krustup P, Gonzalez-Alonso J, and Saltin B. Enhanced pyruvate dehydrogenase activity does not affect muscle O2 uptake at onset of intense exercise in humans. Am J Physiol Regul Integr Comp Physiol 282: R273-R280, 2002[Abstract/Free Full Text].

2.   Behnke, BJ, Kindig CA, Musch TI, Koga S, and Poole DC. Dynamics of microvascular oxygen pressure across the rest-exercise transition in rat skeletal muscle. Respir Physiol 126: 53-63, 2001[ISI][Medline].

3.   Elzinga, G, and van der Laarse WJ. Oxygen consumption of single muscle fibres of Rana Temporaria and Xenopus Laevis at 20°C. J Physiol 399: 405-418, 1988[Abstract/Free Full Text].

4.   Evans, MK, Savasi I, Heigenhauser GJF, and Spriet LL. Effects of acetate infusion and hyperoxia on muscle substrate phosphorylation after onset of moderate exercise. Am J Physiol Endocrinol Metab 281: E1144-E1150, 2001[Abstract/Free Full Text].

5.   Gerbino, A, Ward SA, and Whipp BJ. Effects of prior exercise on pulmonary gas-exchange kinetics during high-intensity exercise in humans. J Appl Physiol 80: 99-107, 1996[Abstract/Free Full Text].

6.   Grassi, B. Regulation of oxygen consumption at exercise onset: is it really controversial? Exerc Sport Sci Rev 29: 134-138, 2001[Medline].

7.   Grassi, B, Gladden LB, Samaja M, Stary CM, and Hogan MC. Faster adjustment of O2 delivery does not affect VO2 on-kinetics in isolated in situ canine muscle. J Appl Physiol 85: 1394-1403, 1998[Abstract/Free Full Text].

8.   Grassi, B, Gladden LB, Stary CM, Wagner PD, and Hogan MC. Peripheral O2 diffusion does not affect VO2 on-kinetics in isolated in situ canine muscle. J Appl Physiol 85: 1404-1412, 1998[Abstract/Free Full Text].

9.   Grassi, B, Hogan MC, Greenhaff PL, Hamann JJ, Kelley KM, Aschenbach WG, Constantin-Teodosiu D, and Gladden LB. VO2 on-kinetics in dog gastrocnemius in situ following activation of pyruvate dehydrogenase by dichloroacetate. J Physiol 538: 195-207, 2002[Abstract/Free Full Text].

10.   Grassi, B, Hogan MC, Kelley KM, Aschenbach WG, Hamann JJ, Evans RK, Patillo RE, and Gladden LB. Role of convective O2 delivery in determining VO2 on-kinetics in canine muscle contracting at peak VO2. J Appl Physiol 89: 1293-1301, 2000[Abstract/Free Full Text].

11.   Hogan, MC. Phosphorescence quenching method for measurement of intracellular PO2 in isolated skeletal muscle fibers. J Appl Physiol 86: 720-724, 1999[Abstract/Free Full Text].

12.   Hogan, MC. Fall in intracellular PO2 at the onset of contractions in Xenopus single skeletal muscle fibers. J Appl Physiol 90: 1871-1876, 2001[Abstract/Free Full Text].

13.   Howlett, RA, Heigenhauser GJF, Hultman E, Hollidge-Horvat MG, and Spriet LL. Effects of dichloroacetate infusion on human skeletal muscle metabolism at the onset of exercise. Am J Physiol Endocrinol Metab 277: E18-E25, 1999[Abstract/Free Full Text].

14.   Howlett, RA, Heigenhauser GJF, and Spriet LL. Skeletal muscle metabolism during high-intensity sprint exercise is unaffected by dichloroacetate or acetate infusion. J Appl Physiol 87: 1747-1751, 1999[Abstract/Free Full Text].

15.   Howlett, RA, and Hogan MC. Intracellular PO2 decreases with increasing stimulation frequency in contracting single Xenopus muscle fibers. J Appl Physiol 91: 632-636, 2001[Abstract/Free Full Text].

16.   Hughson, RL, Tschakovsky ME, and Houston ME. Regulation of oxygen consumption at the onset of exercise. Exerc Sport Sci Rev 29: 129-133, 2001[Medline].

17.   Kindig, CA, McDonough P, Erickson HH, and Poole DC. Effect of L-NAME on oxygen uptake kinetics during heavy-intensity exercise in the horse. J Appl Physiol 91: 891-896, 2001[Abstract/Free Full Text].

18.   MacDonald, M, Pedersen PK, and Hughson RL. Acceleration of VO2 kinetics in heavy submaximal exercise by hyperoxia and prior high-intensity exercise. J Appl Physiol 83: 1318-1325, 1997[Abstract/Free Full Text].

19.   Richardson, RS, Grassi B, Gavin TP, Haseler LJ, Tagore K, Roca J, and Wagner PD. Evidence of O2 supply-dependent VO2 max in the exercise-trained human quadriceps. J Appl Physiol 86: 1048-1053, 1999[Abstract/Free Full Text].

20.   Richardson, RS, Leigh JS, Wagner PD, and Noyszewski EA. Cellular PO2 as a determinant of maximal mitochondrial O2 consumption in trained human skeletal muscle. J Appl Physiol 87: 325-331, 1999[Abstract/Free Full Text].

21.   Shen, W, Xu X, Ochoa M, Zhao G, Bernstein RD, Forfia P, and Hintze TH. Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise. Acta Physiol Scand 168: 675-686, 2000[ISI][Medline].

22.   Shoemaker, JK, Halliwill JR, Hughson RL, and Joyner MJ. Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol Heart Circ Physiol 273: H2388-H2395, 1997[Abstract/Free Full Text].

23.   Timmons, JA, Gustafsson T, Sundberg CJ, Jansson E, and Greenhaff PL. Muscle acetyl group availability is a major determinant of oxygen deficit in humans during submaximal exercise. Am J Physiol Endocrinol Metab 274: E377-E380, 1998[Abstract/Free Full Text].

24.   Timmons, JA, Poucher SM, Constantin-Teodosiu D, Macdonald IA, and Greenhaff PL. Metabolic responses from rest to steady state determine contractile function in ischemic skeletal muscle. Am J Physiol Endocrinol Metab 273: E233-E238, 1997[Abstract/Free Full Text].

25.   Timmons, JA, Poucher SM, Constantin-Teodosiu D, Worrall V, Macdonald IA, and Greenhaff PL. Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia. J Clin Invest 97: 879-883, 1996[ISI][Medline].

26.   Tschakovsky, ME, and Hughson RL. Interaction of factors determining oxygen uptake at the onset of exercise. J Appl Physiol 86: 1101-1113, 1999[Abstract/Free Full Text].

27.   Van der Laarse, WJ, Diegenbach PC, and Elzinga G. Maximum rate of oxygen consumption and quantitative histochemistry of succinate dehydrogenase in single muscle fibres of Xenopus laevis. J Muscle Res Cell Motil 10: 221-228, 1989[ISI][Medline].

28.   Vanderkooi, JM, Maniara G, Green TJ, and Wilson DF. An optical method for measurement of dioxygen concentration based upon quenching of phosphorescence. J Biol Chem 262: 5476-5482, 1987[Abstract/Free Full Text].

29.   Wells, PG, Moore GW, Rabin D, Wilkinson GR, Oates JA, and Stacpoole PW. Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans. Diabetologia 19: 109-113, 1980[ISI][Medline].

30.   Whipp, BJ, and Mahler M. Dynamics of pulmonary gas exchange during exercise. In: Pulmonary Gas Exchange, edited by West JB.. New York: Academic, 1980, vol. II, p. 33-95.


Am J Physiol Regul Integr Comp Physiol 284(2):R481-R485
0363-6119/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
Exp PhysiolHome page
B. Walsh, C. M. Stary, R. A. Howlett, K. M. Kelley, and M. C. Hogan
Glycolytic activation at the onset of contractions in isolated Xenopus laevis single myofibres
Exp Physiol, September 1, 2008; 93(9): 1076 - 1084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. J. Gurd, S. J. Peters, G. J. F. Heigenhauser, P. J. LeBlanc, T. J. Doherty, D. H. Paterson, and J. M. Kowalchuk
O2 uptake kinetics, pyruvate dehydrogenase activity, and muscle deoxygenation in young and older adults during the transition to moderate-intensity exercise
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R577 - R584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. Glancy, T. Barstow, and W. T. Willis
Linear relation between time constant of oxygen uptake kinetics, total creatine, and mitochondrial content in vitro
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C79 - C87.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. A. Howlett, C. A. Kindig, and M. C. Hogan
Intracellular PO2 kinetics at different contraction frequencies in Xenopus single skeletal muscle fibers
J Appl Physiol, April 1, 2007; 102(4): 1456 - 1461.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. J. Gurd, S. J. Peters, G. J. F. Heigenhauser, P. J. LeBlanc, T. J. Doherty, D. H. Paterson, and J. M. Kowalchuk
Prior heavy exercise elevates pyruvate dehydrogenase activity and speeds O2 uptake kinetics during subsequent moderate-intensity exercise in healthy young adults
J. Physiol., December 15, 2006; 577(3): 985 - 996.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Burnley, J. H. Doust, and A. M. Jones
Time required for the restoration of normal heavy exercise VO2 kinetics following prior heavy exercise
J Appl Physiol, November 1, 2006; 101(5): 1320 - 1327.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. M. Stary and M. C. Hogan
Intracellular pH during sequential, fatiguing contractile periods in isolated single Xenopus skeletal muscle fibers
J Appl Physiol, July 1, 2005; 99(1): 308 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. J. Gurd, B. W. Scheuermann, D. H. Paterson, and J. M. Kowalchuk
Prior heavy-intensity exercise speeds V{middle dot}O2 kinetics during moderate-intensity exercise in young adults
J Appl Physiol, April 1, 2005; 98(4): 1371 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. A. Kindig, C. M. Stary, and M. C. Hogan
Effect of dissociating cytosolic calcium and metabolic rate on intracellular PO2 kinetics in single frog myocytes
J. Physiol., January 15, 2005; 562(2): 527 - 534.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. A Timmons, D. Constantin-Teodosiu, S. M Poucher, and P. L Greenhaff
Acetyl group availability influences phosphocreatine degradation even during intense muscle contraction
J. Physiol., December 15, 2004; 561(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Endo, S. Tauchi, N. Hayashi, S. Koga, H. B. Rossiter, and Y. Fukuba
Facial cooling-induced bradycardia does not slow pulmonary V.O2 kinetics at the onset of high-intensity exercise
J Appl Physiol, October 1, 2003; 95(4): 1623 - 1631.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/2/R481    most recent
00078.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howlett, R. A.
Right arrow Articles by Hogan, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howlett, R. A.
Right arrow Articles by Hogan, M. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online